Survivorship Post-HCT Optimization Program
S-POP
The Effect of High-intensity Interval Training (HIIT) and Resistance Training on Function, Health, and Quality of Life Outcomes Following Hematopoietic Stem Cell Transplant
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of this project is to investigate the effects of 12 weeks of high-intensity interval training (HIIT) and resistance training on several domains of health including physical function, cognitive function, mental health, and quality of life in patients who have undergone hematopoietic stem cell transplant (HCT). In addition, the project will determine the effects of 12 weeks of HIIT and resistance training on physical function, caregiver strain, mental health, and caregiver confidence in individuals who are providing care for patients undergoing HCT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2022
CompletedFirst Posted
Study publicly available on registry
February 14, 2022
CompletedStudy Start
First participant enrolled
December 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 23, 2025
CompletedSeptember 26, 2025
September 1, 2025
2.2 years
February 2, 2022
September 25, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Adherence to prescribed exercise program, as measured by number of total sessions completed
12 weeks
Compliance to prescribed HIIT sessions, as measured by total session time (in minutes)
12 weeks
Compliance to prescribed HIIT sessions, as measured by number of intervals completed
12 weeks
Compliance to prescribed HIIT sessions, as measured by number/percentage of intervals meeting target heart rates
12 weeks
Compliance to prescribed resistance sessions, as measured by number of sets completed
12 weeks
Compliance to prescribed resistance sessions, as measured by number of repetitions completed
12 weeks
Secondary Outcomes (62)
Change in physical function/activity, as measured by SPPB
Baseline, Post-intervention (week 12), 1 Year
Change in physical function/activity, as measured by 6-minute walk test
Baseline, Post-intervention (week 12), 1 Year
Change in physical function/activity, as measured by 30-second sit-to-stand
Baseline, Post-intervention (week 12), 1 Year
Change in physical function/activity, as measured by grip strength
Baseline, Post-intervention (week 12), 1 Year
Change in physical function/activity, as measured by Fried Frailty
Baseline, Post-intervention (week 12), 1 Year
- +57 more secondary outcomes
Study Arms (2)
Patient
EXPERIMENTALThese are patients who are 90 (±30) days post-allogeneic hematopoietic stem cell transplant. Patients will complete 12 weeks of exercise training. Patients will also complete assessments to evaluate physical function, cognitive function, mental health, social support, nutrition and diet, symptoms, quality of life, and financial status. They will use devices to capture activity data and vital signs. They will collect bio-specimens to assess microbiota and biomarkers.
Caregiver
EXPERIMENTALThese are the assigned caregivers for the transplant patients. Caregivers will complete 12 weeks of exercise training. Caregivers will also complete assessments to evaluate physical function, caregiver support, and physical activity and exercise. They will collect bio-specimens to assess microbiota.
Interventions
12 weeks of high intensity interval training (HIIT) (3x/week) and resistance training (2x/week)
Eligibility Criteria
You may qualify if:
- ≥18 years old
- English speaking
- Within 90 ± 30 days post allogenic HCT
- ≥18 years old
- English speaking
- Providing post-discharge care for the patient who has undergone HCT
You may not qualify if:
- Have an absolute contraindication to exercise including a recent acute cardiac event (\<6 months), unstable angina, uncontrolled dysthymias causing symptoms or hemodynamic compromise, symptomatic aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus, acute myocarditis or pericarditis, suspects or known dissecting aneurism, or coronary artery disease.
- In addition to these absolute contraindications, the patient and caregiver will complete cardiopulmonary exercise testing (CPET) where the heart rate and heart rhythm will be monitored via a 12-lead ECG before, during, and after the test. The results from the CPET will be reviewed by a physician before the subject is cleared to participate in the HIIT and resistance training program. If the participant is not cleared by the physician following the CPET, then the patient and his or her caregiver will not be eligible to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke Adult Blood and Marrow Transplant Clinic
Durham, North Carolina, 27705, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chenyu Lin, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2022
First Posted
February 14, 2022
Study Start
December 2, 2022
Primary Completion
February 26, 2025
Study Completion
March 23, 2025
Last Updated
September 26, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share